Literature DB >> 21734786

Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome.

Pejman Katiraei1, Gilberto Bultron.   

Abstract

Irritable bowel syndrome (IBS) is defined by the Rome III criteria as symptoms of recurrent abdominal pain or discomfort with the onset of a marked change in bowel habits with no evidence of an inflammatory, anatomic, metabolic, or neoplastic process. As such, many clinicians regard IBS as a central nervous system problem of altered pain perception. Here, we review the recent literature and discuss the evidence that supports an organic based model, which views IBS as a complex, heterogeneous, inter-dependent, and multi-variable inflammatory process along the neuronal-gut axis. We delineate the organic pathophysiology of IBS, demonstrate the role of inflammation in IBS, review the possible differences between adult and pediatric IBS, discuss the merits of a comprehensive treatment model as taught by the Institute of Functional Medicine, and describe the potential for future research for this syndrome.

Entities:  

Keywords:  Abdominal pain; Inflammation; Irritable bowel syndrome; Probiotics; Stress

Mesh:

Substances:

Year:  2011        PMID: 21734786      PMCID: PMC3120938          DOI: 10.3748/wjg.v17.i23.2791

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  199 in total

1.  Long-term prognosis in children with recurrent abdominal pain.

Authors:  M F Christensen; O Mortensen
Journal:  Arch Dis Child       Date:  1975-02       Impact factor: 3.791

2.  Sympathetic nerve contact causes maturation of mast cells in vitro.

Authors:  M G Blennerhassett; J Bienenstock
Journal:  J Neurobiol       Date:  1998-05

3.  Repeated antigen challenge in rats induces a mucosal mast cell hyperplasia.

Authors:  J S Marshall
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

4.  Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.

Authors:  Christel Rousseaux; Xavier Thuru; Agathe Gelot; Nicolas Barnich; Christel Neut; Laurent Dubuquoy; Caroline Dubuquoy; Emilie Merour; Karen Geboes; Mathias Chamaillard; Arthur Ouwehand; Greg Leyer; Didier Carcano; Jean-Frédéric Colombel; Denis Ardid; Pierre Desreumaux
Journal:  Nat Med       Date:  2006-12-10       Impact factor: 53.440

5.  Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome.

Authors:  F Creed; J Ratcliffe; L Fernandez; B Tomenson; S Palmer; C Rigby; E Guthrie; N Read; D Thompson
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

6.  Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis.

Authors:  L-H Wang; X-C Fang; G-Z Pan
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

7.  Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.

Authors:  M Majewski; R W McCallum
Journal:  Adv Med Sci       Date:  2007       Impact factor: 3.287

8.  Differential responsiveness of purified mouse c-kit+ mast cells and their progenitors to IL-3 and stem cell factor.

Authors:  C S Lantz; T F Huff
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

Review 9.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  A C Ford; N J Talley; P S Schoenfeld; E M M Quigley; P Moayyedi
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059

Review 10.  Role of neuropeptides in inflammatory bowel disease.

Authors:  Kara J Gross; Charalabos Pothoulakis
Journal:  Inflamm Bowel Dis       Date:  2007-07       Impact factor: 5.325

View more
  4 in total

1.  Irritable bowel syndrome correlates with increased risk of Parkinson's disease in Taiwan.

Authors:  Shih-Wei Lai; Kuan-Fu Liao; Cheng-Li Lin; Fung-Chang Sung
Journal:  Eur J Epidemiol       Date:  2014-01-18       Impact factor: 8.082

2.  Irritable bowel syndrome and organic diseases: a comparative analysis of esophageal motility.

Authors:  Thomas Thomaidis; Martin Goetz; Sebastian Paul Gregor; Arthur Hoffman; Elias Kouroumalis; Markus Moehler; Peter Robert Galle; Andreas Schwarting; Ralf Kiesslich
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

Review 3.  Complementary and alternative medicines in irritable bowel syndrome: an integrative view.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

4.  Acupuncture and Moxibustion in the Treatment of Adult Diarrhea Irritable Bowel Syndrome: A Network Meta-analysis.

Authors:  Xiaoxue Jiang; Xiutian Guo; Jianhua Zhou; Sunsong Ye
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.